Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Aphria Inc. (TSX:APHA) APHA reported a second-quarter net loss of CA$7.9 million ($6.1 million) or CA$0.03 per share versus Tuesday versus net income of CA$16.4 million, or CA$0.07 per share, in the first quarter.
The Aphria Analyst
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Cantor Fitzgerald’s Pablo Zuanic maintained an Overweight rating on Aphria with a CA$9.90 ($7.58) price target.
Don't allow your company to miss out on North America's largest B2B gathering of experts, thought leaders, investors, and cannabis executives!
The Aphria Thesis
The company’s total sales of CA$120.6 million were lower than Cantor's estimate of CA$124.4 million and the consensus estimate of CA$130 million, while core cannabis sales beat by Cantor's estimate by CA$3 million and the German distribution unit missed by CA$8 million, Zuanic said in a Tuesday note. (See his track record here.)
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Aphria’s medical cannabis revenues were mostly stable, the analyst said, adding that bulk sales reached only CA$0.4 million versus compared to CA$4.9 million in the prior quarter.
“The company says demand was ahead of its own supply so it had to buy in the wholesale market,” Zuanic said.
Aphria posted improved cannabis EBITDA of CA$3.4 million, compared to the previous quarter's CA$1.3 million. Cantor had expected cannabis EBITDA of CA$3.2 million, and the consensus estimate was CA$1 million.
The company lowered its fiscal year 2020 sales guidance by CA$75 million to a range of CA$575 million to CA$625 million, and distribution by more than half. Zuanic said he considers this a combined cut in distribution and cannabis.
The lower cannabis guidance is due to the passive launch of new stores and vape bans in combination with later-than-projected licensing of Aphria Diamond, the analyst said.
Aphria Price Action
Aphria shares were down 4.95% at $5.18 at the time of publication Tuesday.
Photo courtesy of Aphria.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.